Focus Brief: Market Access Weekly September 1 to 7, 2025
Global market access shifts: HTA speed, UK pricing, digital disruption.
Read MorePosted by Shajini | Sep 9, 2025 | News, Pricing & Market Access, Weekly Pulse |
Global market access shifts: HTA speed, UK pricing, digital disruption.
Read MorePosted by Shajini | Sep 8, 2025 | Dealstreet, News, Weekly Pulse |
Healthcare deal spotlight September 1 to 7, 2025
Read MorePosted by Shajini | Jul 1, 2025 | News, Pricing & Market Access
NCPE recommends Omeprazole Appizped for reimbursement eligibility.
Read MorePosted by Shajini | Jul 1, 2025 | News, Pricing & Market Access
NCPE recommends Vabysmo for neovascular (wet) age-related macular degeneration treatment.
Read MorePosted by Shajini | Jun 27, 2025 | Dealstreet, News |
Sanofi, Gilead sign License Agreement with Kymera for protein degrader programs.
Read More